Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Revenue (2016 - 2023)

Aethlon Medical (AEMD) has disclosed Revenue for 13 consecutive years, with $574245.0 as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Revenue rose 4278.2% year-over-year to $574245.0, compared with a TTM value of $574245.0 through Dec 2023, up 4278.2%, and an annual FY2025 reading of -$4.7 million, changed N/A over the prior year.
  • Revenue was $574245.0 for Q1 2023 at Aethlon Medical, up from $13116.0 in the prior quarter.
  • Across five years, Revenue topped out at $624871.0 in Q4 2020 and bottomed at $13116.0 in Q1 2022.
  • Average Revenue over 5 years is $205245.5, with a median of $131966.0 recorded in 2021.
  • The sharpest move saw Revenue tumbled 97.26% in 2021, then soared 4278.2% in 2023.
  • Year by year, Revenue stood at $413458.0 in 2019, then surged by 51.13% to $624871.0 in 2020, then crashed by 97.26% to $17117.0 in 2021, then fell by 23.37% to $13116.0 in 2022, then skyrocketed by 4278.2% to $574245.0 in 2023.
  • Business Quant data shows Revenue for AEMD at $574245.0 in Q1 2023, $13116.0 in Q1 2022, and $17117.0 in Q4 2021.